• Graduate Program
  • Research
  • Browse our Courses
  • Events
    • Events Calendar
    • Events Archive
    • Tinbergen Institute Lectures
    • Summer School
      • Deep Learning
      • Economics of Blockchain and Digital Currencies
      • Foundations of Machine Learning with Applications in Python
      • Marketing Research with Purpose
      • Modern Toolbox for Spatial and Functional Data
      • Sustainable Finance
      • Tuition Fees and Payment
      • Tinbergen Institute Summer School Program
    • Annual Tinbergen Institute Conference archive
  • News
  • Summer School
    • Deep Learning
    • Economics of Blockchain and Digital Currencies
    • Foundations of Machine Learning with Applications in Python
    • Marketing Research with Purpose
    • Modern Toolbox for Spatial and Functional Data
    • Sustainable Finance
  • Alumni

Groot, W., Maassen van den Brink, H. and Plug, E. (2004). Money for health: The equivalent variation of cardiovascular diseases Health Economics, 13(9):859--872.


  • Affiliated author
  • Publication year
    2004
  • Journal
    Health Economics

This paper introduces a new method to calculate the extent to which individuals are willing to trade money for improvements in their health status. An individual welfare function of income (WFI) is applied to calculate the equivalent income variation of health impairments. We believe that this approach avoids various drawbacks of alternative willingness-to-pay methods. The WFI is used to calculate the equivalent variation of cardiovascular diseases. It is found that for a 25 year old male the equivalent variation of a heart disease ranges from 114 000 to 380 000 depending on the welfare level. This is about 10 000-30 000 for an additional life year. The equivalent variation declines with age and is about the same for men and women. The estimates further vary by discount rate chosen. The estimates of the equivalent variation are generally higher than the money spent on most heart-related medical interventions per QALY. The cost-benefit analysis shows that for most interventions the value of the health benefits exceeds the costs. Heart transplants seem to be too costly and only beneficial if patients are young.